Ameriprise
OGN icon

Ameriprise’s Organon & Co OGN Stock Holding History

Ameriprise’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.98M Sell
663,233
-91,007
-12% -$1.09M ﹤0.01% 2127
2026
Q1 		$4.52M Buy
754,240
+123,442
+20% +$929K ﹤0.01% 2501
2025
Q4 		$4.52M Buy
630,798
+46,210
+8% +$365K ﹤0.01% 2508
2025
Q3 		$6.24M Sell
584,588
-117,541
-17% -$1.15M ﹤0.01% 2265
2025
Q2 		$6.8M Sell
702,129
-1,466
-0.2% -$15.1K ﹤0.01% 2111
2025
Q1 		$10.5M Sell
703,595
-33,748
-5% -$519K ﹤0.01% 1731
2024
Q4 		$11M Sell
737,343
-137,190
-16% -$2.24M ﹤0.01% 1722
2024
Q3 		$16.7M Sell
874,533
-48,226
-5% -$1,000K ﹤0.01% 1435
2024
Q2 		$19.1M Sell
922,759
-34,069
-4% -$677K 0.01% 1309
2024
Q1 		$18M Buy
956,828
+26,283
+3% +$451K 0.01% 1373
2023
Q4 		$13.4M Buy
930,545
+704,996
+313% +$9.59M ﹤0.01% 1537
2023
Q3 		$3.91M Buy
225,549
+71,684
+47% +$1.49M ﹤0.01% 2469
2023
Q2 		$3.26M Sell
153,865
-35,675
-19% -$775K ﹤0.01% 2624
2023
Q1 		$4.46M Buy
189,540
+5,082
+3% +$136K ﹤0.01% 2401
2022
Q4 		$5.15M Sell
184,458
-120,509
-40% -$3.08M ﹤0.01% 2273
2022
Q3 		$7.14M Sell
304,967
-329,587
-52% -$9.95M ﹤0.01% 1959
2022
Q2 		$21.4M Sell
634,554
-48,535
-7% -$1.7M 0.01% 1169
2022
Q1 		$23.9M Buy
683,089
+53,577
+9% +$1.83M 0.01% 1217
2021
Q4 		$19.2M Buy
629,512
+41,479
+7% +$1.35M 0.01% 1442
2021
Q3 		$19.3M Buy
588,033
+266,657
+83% +$8.53M 0.01% 1292
2021
Q2 		$9.72M Buy
+321,376
New +$10.6M ﹤0.01% 1962

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Ameriprise's OGN Position: Q2 2026 in Review

Ameriprise reduced its Organon & Co (OGN) stake by 12% in Q2 2026, selling an estimated $1.09M and leaving 663,233 shares worth $8.98M. The position accounts for ﹤0.01% of the portfolio, ranked #2127.

Ameriprise first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $23.9M in Q1 2022. 634 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Ameriprise held 663,233 shares of Organon & Co worth $8.98M as of Q2 2026.
  • Ameriprise sold 91,007 Organon & Co shares in Q2 2026, an estimated $1.09M.
  • Organon & Co made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2127 holding.
  • Ameriprise first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Ameriprise's Organon & Co position peaked at $23.9M in Q1 2022.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.